MedPath

HEMAREXIN LIQ

HEMAREXIN LIQ

Discontinued
DIN Number

01922742

Drug Class

Human

Market Date

Dec 22, 1993

Company
HC

lab bio chimique inc.,division of technilab pharma inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number01922742
AIG Number0900366001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A11JC VITAMINS, OTHER COMBINATIONS
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification88:28.01*
Health Canada Classification

ACTIVE INGREDIENTS (9)

CALCIUM GLYCEROPHOSPHATEActive
Strength: 12.5 MG / 5 ML
Monograph: CALCIUM GLYCEROPHOSPHATE
KOLAActive
Strength: 100 MG / 5 ML
Monograph: KOLA
LIVER EXTRACTActive
Strength: 53 MG / 5 ML
Monograph: LIVER EXTRACT
MAGNESIUM CHLORIDEActive
Strength: 25 MG / 5 ML
Monograph: MAGNESIUM CHLORIDE
NICOTINAMIDEActive
Strength: 5 MG / 5 ML
Monograph: NICOTINAMIDE
PHOSPHORIC ACIDActive
Strength: 13.75 MG / 5 ML
Monograph: PHOSPHORIC ACID
SODIUM GLYCEROPHOSPHATEActive
Strength: 12.5 MG / 5 ML
Monograph: SODIUM GLYCEROPHOSPHATE
THIAMINE HYDROCHLORIDEActive
Strength: .5 MG / 5 ML
Monograph: THIAMINE HYDROCHLORIDE
VITAMIN B2Active
Strength: .5 MG / 5 ML
Monograph: VITAMIN B2

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.